SANTEN PHARMA.SANTEN PHARMA.SANTEN PHARMA.

SANTEN PHARMA.

No trades
See on Supercharts

SZD fundamentals

SANTEN PHARMA. financial statements, including revenue, expenses, profit, and loss

The total revenue of SZD for the last quarter is 484.55 M EUR, and it's 2.03% lower compared to the previous quarter. The net income of Q4 23 is 183.70 k EUR.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth